Women have mixed success at drug companies

they should try this study for engineering companies...

WASHINGTON (Reuters) - Top women executives do slightly better at U.S.-based healthcare and pharmaceutical companies than in other industries, but 35 percent of big drug companies do not have a single female director, according to a new survey.

The survey by Corporate Women Directors International found that 16 percent of directors at U.S.-based healthcare and pharmaceutical companies are women -- slightly more than the national average for all companies of just under 15 percent.

But nearly 36 percent of Financial Times 500 companies did not have any female directors, including industry giant GlaxoSmithKline, the report found.

"While we see promise among some companies -- particularly those based in the United States -- there is a shocking number of companies with absolutely no female representation at all," said Irene Natividad, co-chair of Corporate Women Directors International.

link to full article